Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.

Fournier MR, Targownik LE, Leslie WD.

Maturitas. 2009 Sep 20;64(1):9-13. doi: 10.1016/j.maturitas.2009.07.006. Epub 2009 Aug 11. Review.

PMID:
19674854
2.

The effect of proton pump-inhibiting drugs on mineral metabolism.

Insogna KL.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S2-4. doi: 10.1038/ajg.2009.44. Review.

PMID:
19262542
3.

Proton pump-inhibiting drugs, calcium homeostasis, and bone health.

Wright MJ, Proctor DD, Insogna KL, Kerstetter JE.

Nutr Rev. 2008 Feb;66(2):103-8. doi: 10.1111/j.1753-4887.2008.00015.x. Review.

PMID:
18254877
4.

[Chronic use of proton pump inhibitors: is the risk of osteoporosis and fractures real?].

Martí-Cabrera M, Martí-Masanet M, Esplugues JV.

Gastroenterol Hepatol. 2011 Apr;34(4):271-7. doi: 10.1016/j.gastrohep.2011.01.002. Epub 2011 Mar 17. Review. Spanish.

PMID:
21419526
5.

Proton pump inhibitors and bone fractures?

Laine L.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S21-6. doi: 10.1038/ajg.2009.48. Review.

PMID:
19262543
6.

Use of proton pump inhibitors and risk of osteoporosis-related fractures.

Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD.

CMAJ. 2008 Aug 12;179(4):319-26. doi: 10.1503/cmaj.071330.

7.

Fracture risk and bone mineral density reduction associated with proton pump inhibitors.

Lau YT, Ahmed NN.

Pharmacotherapy. 2012 Jan;32(1):67-79. doi: 10.1002/PHAR.1007. Review.

PMID:
22392829
8.

The relationship among proton pump inhibitors, bone disease and fracture.

Targownik LE, Leslie WD.

Expert Opin Drug Saf. 2011 Nov;10(6):901-12. doi: 10.1517/14740338.2011.586628. Epub 2011 May 20. Review.

PMID:
21599546
9.

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.

Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K.

Am J Gastroenterol. 2011 Jul;106(7):1209-18; quiz 1219. doi: 10.1038/ajg.2011.113. Epub 2011 Apr 12. Review.

PMID:
21483462
10.

[Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?].

Maléth J, Hegyi P.

Orv Hetil. 2013 Jun 30;154(26):1005-9. doi: 10.1556/OH.2013.29656. Review. Hungarian.

PMID:
23800385
11.

The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).

Targownik LE, Leslie WD, Davison KS, Goltzman D, Jamal SA, Kreiger N, Josse RG, Kaiser SM, Kovacs CS, Prior JC, Zhou W; CaMos Research Group.

Am J Gastroenterol. 2012 Sep;107(9):1361-9. doi: 10.1038/ajg.2012.200. Epub 2012 Jul 10. Erratum in: Am J Gastroenterol. 2013 Jan;108(1):157.

12.

[Risk of long-term treatment with proton pump inhibitors].

Mathieu N.

Rev Prat. 2008 Sep 15;58(13):1451-4. French.

PMID:
18924330
13.

Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.

Kaye JA, Jick H.

Pharmacotherapy. 2008 Aug;28(8):951-9. doi: 10.1592/phco.28.8.951.

PMID:
18657011
14.

Long-term safety concerns with proton pump inhibitors.

Ali T, Roberts DN, Tierney WM.

Am J Med. 2009 Oct;122(10):896-903. doi: 10.1016/j.amjmed.2009.04.014. Review.

PMID:
19786155
15.

Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.

Targownik LE, Lix LM, Leung S, Leslie WD.

Gastroenterology. 2010 Mar;138(3):896-904. doi: 10.1053/j.gastro.2009.11.014. Epub 2009 Nov 18.

PMID:
19931262
16.

[Drug-induced osteoporosis].

Briot K.

Rev Prat. 2012 Feb;62(2):187-92. Review. French.

PMID:
22408857
17.
18.

Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.

Moayyedi P, Cranney A.

Am J Gastroenterol. 2008 Oct;103(10):2428-31. doi: 10.1111/j.1572-0241.2008.02031.x. Review.

PMID:
18855852
19.

[Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs].

Suzuki H.

Clin Calcium. 2013 Sep;23(9):1307-12. doi: CliCa130913071312. Review. Japanese.

PMID:
23999367
20.

Long-term acid inhibition: benefits and harms.

Tepeš B.

Dig Dis. 2011;29(5):476-81. doi: 10.1159/000331519. Epub 2011 Nov 16. Review.

PMID:
22095013

Supplemental Content

Support Center